Helius Medical Technologies Inc Class A

NASDAQ HSDT

Download Data

Helius Medical Technologies Inc Class A Revenue for the year ending December 31, 2023: USD 644.00 K

Helius Medical Technologies Inc Class A Revenue is USD 644.00 K for the year ending December 31, 2023, a -18.17% change year over year. The revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Helius Medical Technologies Inc Class A Revenue for the year ending December 31, 2022 was USD 787.00 K, a 50.77% change year over year.
  • Helius Medical Technologies Inc Class A Revenue for the year ending December 31, 2021 was USD 522.00 K, a -21.03% change year over year.
  • Helius Medical Technologies Inc Class A Revenue for the year ending December 31, 2020 was USD 661.00 K, a -55.82% change year over year.
  • Helius Medical Technologies Inc Class A Revenue for the year ending December 31, 2019 was USD 1.50 M, a 212.97% change year over year.
NASDAQ: HSDT

Helius Medical Technologies Inc Class A

CEO Mr. Dane Carl Andreeff
IPO Date June 27, 2014
Location United States
Headquarters 642 Newtown Yardley Road, Newtown, PA, United States, 18940
Employees 22
Sector Healthcare
Industry Medical devices
Description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

StockViz Staff

September 16, 2024

Any question? Send us an email